Tazorac Cream, 0.1%

DRUG2 trials

Sponsors

G & W Laboratories Inc., Dr. Reddy's Laboratories Limited

Conditions

Acne Vulgaris

Phase 2

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

CompletedNCT03341910

Dr. Reddy's Laboratories LimitedAcne Vulgaris

Start: 2017-08-21End: 2018-05-18Updated: 2020-08-17

Phase 3

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

CompletedNCT02160678

G & W Laboratories Inc.Acne Vulgaris

Start: 2014-05-31End: 2015-07-31Updated: 2016-11-03